abstract |
The present invention provides compounds of formula I which function as inhibitors of BCL6 (B cell lymphoma 6) activity. Where X 1 , X 2 , R 1 , R 2 and R 3 are each as defined herein. The present invention also relates to processes for preparing these compounds, pharmaceutical compositions containing them and their use in the treatment of proliferative diseases such as cancer as well as other diseases or conditions associated with BCL6 activity. Regarding |